##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H074-301222-ROCHE_S22_R
1	12793226	.	N	<DUP>	.	.	Type=Gain;Targets=18;Samples2=2;Span=100277;GeneNames=HNRNPCL1,LINC01784,PRAMEF1,PRAMEF2,PRAMEF4,PRAMEF10,PRAMEF11;GeneIDs=65121,105376745,440560,343069,65122,400735,343071;Genes=7;TranscriptNameClinicallyRelevant=NM_001013631.3,NR_146629.1,NM_023013.4,NM_023014.1,NM_001009611.4,NM_001039361.4,NM_001146344.3;OverlappingExonsClinicallyRelevant=All,All,2-4,All,All,4,All;HGVSg=NC_000001.11:g.12793226_12893502dup;HGVScClinicallyRelevant=.,.,.,.,.,NM_001039361.4:c.867-28_1425dup,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.;ISCNCytobandNotation=dup(1)p36.21;SequenceOntologyClinicallyRelevant=.,.,.,.,.,transcript_ablation,.;RegionClinicallyRelevant=.,.,.,.,.,exon,.;Region=1:12771339-13127228,1:12774773-12911690,1:12778601-12992795,1:12779834-12859897,1:12785720-12832166,1:12806942-12860808,1:12831630-12893635,1:12833755-12866523,1:12848985-12889447;Span2=355890,136918,214195,80064,46447,53867,62006,32769,40463;OverlapType=Within Region,Within Region,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Contains Region,Contains Region;Name=gssvG344,gssvG349,gssvG347,gssvG354,gssvG368,gssvG362,gssvG359,gssvG371,gssvG369;Frequency=0.0008,0.0267,0.0029,0.0058,0.0061,0.0003,0.194,0.1598,0.129;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=1:12786363-12982850,1:12835724-12872849;Span3=196488,37126;OverlapType2=Within Region,Contains Region;Type3=Duplication,Duplication;Frequency2=0.625,0.2;DeletionFrequency=0,0;DuplicationFrequency=0.625,0.2;END=12893502	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:263.612:1.90319:1.36165:2.28030530955673e-13:HNRNPCL1,LINC01784,PRAMEF1,PRAMEF2,PRAMEF4,PRAMEF10,PRAMEF11::HNRNPCL1:NM_001013631.3:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46308inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	39522383	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=9;Span=120;GeneNames=BMP8A,PPIEL;GeneIDs=353500,728448;Aliases=OP-2;Genes=2;TranscriptNameClinicallyRelevant=NM_181809.4,NR_144356.1;OverlappingExonsClinicallyRelevant=5,14;HGVSg=NC_000001.11:g.39522383_39522502dup;HGVScClinicallyRelevant=NM_181809.4:c.869-20_948+20dup,.;HGVSpClinicallyRelevant=NP_861525.2:p.D317Mfs*53,.;ISCNCytobandNotation=dup(1)p34.3;SequenceOntologyClinicallyRelevant=frameshift_variant,.;RegionClinicallyRelevant=exon,.;END=39522502	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:119.242:3.96913:1.75603:0.000342443800896699:BMP8A,PPIEL::BMP8A:NM_181809.4:Benign:2L0ThiscnvpartiallyoverlapstheBMP8Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	102890417	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=21829;GeneNames=COL11A1;GeneIDs=1301;Aliases=CO11A1,COLL6,DFNA37,STL2;Genes=1;TranscriptNameClinicallyRelevant=NM_001854.4;OverlappingExonsClinicallyRelevant=54-58;HGVSg=NC_000001.11:g.102890417_102912245dup;HGVScClinicallyRelevant=NM_001854.4:c.4033-33_4356+34dup;HGVSpClinicallyRelevant=NP_001845.3:p.P1346_G1453dup;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=102912245	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:45.9646:2.1651:1.3866:9.0551673622073e-05:COL11A1::COL11A1:NM_001854.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL11A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	148639992	.	N	<DUP>	.	.	Type=Gain;Targets=48;Samples2=1;Span=392137;GeneNames=NOTCH2NLB,NUDT4B,PDE4DIP,SEC22B3P;GeneIDs=100996763,440672,100996517,9659;Aliases=N2N,NOTCH2NL;Genes=4;TranscriptNameClinicallyRelevant=NM_001364008.2,NM_001355407.2,NM_001395426.1,NR_158170.1;OverlappingExonsClinicallyRelevant=1-2,All,All,All;HGVSg=NC_000001.11:g.148639992_149032128dup;HGVScClinicallyRelevant=NM_001364008.2:c.1_77+24dup,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(1)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.,.;RegionClinicallyRelevant=exon,.,.,.;Region=1:148768207-148853185,1:148804379-149096946,1:148898662-149026686;Span2=84979,292568,128025;OverlapType=Contains Region,Partial Overlap,Contains Region;Name=gssvG1820,gssvG1774,gssvG1794;Frequency=1,0.0004,0.0004;Type2=Gain,Gain,Gain;Region2=1:148901732-149078491;Span3=176760;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.000337895;DeletionFrequency=0;DuplicationFrequency=0.000337895;END=149032128	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:69.0817:1.95829:1.28858:6.5116380426475e-35:NOTCH2NLB,NUDT4B,PDE4DIP,SEC22B3P::NOTCH2NLB:NM_001364008.2:VUS:2L0ThiscnvpartiallyoverlapstheNOTCH2NLBgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	152213017	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=9;Span=8532;GeneNames=HRNR;GeneIDs=388697;Aliases=FLG3,S100a18;Genes=1;TranscriptNameClinicallyRelevant=NM_001009931.3;OverlappingExonsClinicallyRelevant=3;HGVSg=NC_000001.11:g.152213017_152221548dup;HGVScClinicallyRelevant=NM_001009931.3:c.139-58_8553dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)q21.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=1:152212082-152224248;Span2=12167;OverlapType=Within Region;Name=gssvG2437;Frequency=0.3789;Type2=Gain;END=152221548	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:570.177:3.1744:1.74523:4.95808794185019e-05:HRNR::HRNR:NM_001009931.3:Benign:2L0ThiscnvpartiallyoverlapstheHRNRgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	160623484	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=716;GeneNames=SLAMF1;GeneIDs=6504;Aliases=CD150,CDw150,SLAM;Genes=1;TranscriptNameClinicallyRelevant=NM_003037.5;OverlappingExonsClinicallyRelevant=4;HGVSg=NC_000001.11:g.160623484_160624199dup;HGVScClinicallyRelevant=NM_003037.5:c.701-14_790+612dup;HGVSpClinicallyRelevant=NP_003028.1:p.E234_R263dup;ISCNCytobandNotation=dup(1)q23.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=160624199	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:79.9708:3.29438:1.53502:2.52672310120173e-05:SLAMF1::SLAMF1:NM_003037.5:VUS:2L0ThiscnvpartiallyoverlapstheSLAMF1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	97511137	.	N	<DEL>	.	.	Type=Loss;Targets=11;Samples2=2;Span=34744;GeneNames=ANKRD36B;GeneIDs=57730;Aliases=KIAA1641;Genes=1;TranscriptNameClinicallyRelevant=NM_001393939.1;OverlappingExonsClinicallyRelevant=23-39;HGVSg=NC_000002.12:g.97511137_97545880del;HGVScClinicallyRelevant=NM_001393939.1:c.1580-19_3720+1del;HGVSpClinicallyRelevant=NP_001380868.1:p.V527Gfs*12;ISCNCytobandNotation=del(2)q11.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region=2:97492540-97552005,2:97519753-97552006,2:97524284-97600314;Span2=59466,32254,76031;OverlapType=Within Region,Partial Overlap,Partial Overlap;Name=gssvL64680,gssvL64685,gssvL64676;Frequency=0.0484,0.3985,0.0002;Type2=Loss,Loss,Loss;Region2=2:97523439-97542337;Span3=18899;OverlapType2=Contains Region;Type3=Deletion;Frequency2=0.468288;DeletionFrequency=0.468288;DuplicationFrequency=0;END=97545880	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:44.7161:-1.37449:0.533705:4.08532531430456e-05:ANKRD36B::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
2	191131802	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=120;GeneNames=STAT4;GeneIDs=6775;Aliases=SLEB11;Genes=1;TranscriptNameClinicallyRelevant=NM_003151.4;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000002.12:g.191131802_191131921del;HGVScClinicallyRelevant=NM_003151.4:c.273+14692_273+14811del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(2)q32.3;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;END=191131921	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:34.575:-4.63667:0.434177:2.88006963594537e-05:STAT4::.:.:Benign:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
4	68815951	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=1;Span=14957;GeneNames=UGT2B10;GeneIDs=7365;Aliases=UDPGT2B10;Genes=1;TranscriptNameClinicallyRelevant=NM_001075.6;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000004.12:g.68815951_68830907dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(4)q13.2;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=4:68799853-68871318;Span2=71466;OverlapType=Within Region;Name=gssvG27765;Frequency=0.0081;Type2=Gain;Region2=4:68812470-68852154,4:68812470-68852154,4:68822219-68852015;Span3=39685,39685,29797;OverlapType2=Within Region,Within Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.025,0.0111111,0.00118343;DeletionFrequency=0,0,0;DuplicationFrequency=0.025,0.0111111,0.00118343;END=68830907	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:239.467:4.48552:1.36306:4.79525658313643e-27:UGT2B10::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
5	848473	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=1;Span=30008;GeneNames=BRD9,ZDHHC11;GeneIDs=79844,65980;Aliases=ZNF399;Genes=2;TranscriptNameClinicallyRelevant=NM_023924.5,NM_024786.3;OverlappingExonsClinicallyRelevant=11-16,1-2;HGVSg=NC_000005.10:g.848473_878480dup;HGVScClinicallyRelevant=NM_023924.5:c.1146_1794dup,NM_024786.3:c.1_401+9dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(5)p15.33;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,transcript_ablation;RegionClinicallyRelevant=UTR3,exon;Region=5:772955-886860,5:833513-874903;Span2=113906,41391;OverlapType=Within Region,Partial Overlap;Name=gssvG29115,gssvG29134;Frequency=0.0014,0.0464;Type2=Gain,Gain;Region2=5:817736-874903;Span3=57168;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.000337895;DeletionFrequency=0;DuplicationFrequency=0.000337895;END=878480	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:187.184:3.75117:1.3931:6.06498846823701e-22:BRD9,ZDHHC11::BRD9:NM_023924.5:VUS:2L0ThiscnvpartiallyoverlapstheBRD9genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	177724103	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=1;Span=5455;GeneNames=FAM153A;GeneIDs=285596;Aliases=NY-REN-7;Genes=1;TranscriptNameClinicallyRelevant=NM_001394339.1;OverlappingExonsClinicallyRelevant=17-21;HGVSg=NC_000005.10:g.177724103_177729557del;HGVScClinicallyRelevant=NM_001394339.1:c.863-2_1164del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(5)q35.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=177729557	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:51.5171:-3.574:0.479066:5.06614728103247e-06:FAM153A::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
5	177750899	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=2;Span=2347;GeneNames=FAM153A;GeneIDs=285596;Aliases=NY-REN-7;Genes=1;TranscriptNameClinicallyRelevant=NM_001394339.1;OverlappingExonsClinicallyRelevant=1-2;HGVSg=NC_000005.10:g.177750899_177753245del;HGVScClinicallyRelevant=NM_001394339.1:c.1_175+10del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(5)q35.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=177753245	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:50.587:-3.93014:0.523574:5.14425691732436e-07:FAM153A::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
6	32039052	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=2408;GeneNames=CYP21A2,TNXB;GeneIDs=1589,7148;Aliases=CA21H,CAH1,CYP21,CYP21B,P450c21B;Genes=2;TranscriptNameClinicallyRelevant=NM_000500.9,NM_019105.8;OverlappingExonsClinicallyRelevant=3-10,44;HGVSg=NC_000006.12:g.32039052_32041459dup;HGVScClinicallyRelevant=NM_000500.9:c.293-42_1488dup,NM_019105.8:c.12628-9_12729dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=32041459	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:119.519:1.83989:1.37193:4.55126011810761e-05:CYP21A2,TNXB::CYP21A2:NM_000500.9:Benign:2L0ThiscnvpartiallyoverlapstheCYP21A2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	32642907	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=2;Span=22002;GeneNames=HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1;GeneIDs=3117,3119,106480429;Aliases=CELIAC1,DQ-A1,DQA1,HLA-DQA;Genes=3;TranscriptNameClinicallyRelevant=NM_002122.5,NM_002123.5,NR_133907.1;OverlappingExonsClinicallyRelevant=5,2-5,All;HGVSg=NC_000006.12:g.32642907_32664908del;HGVScClinicallyRelevant=.,NM_002123.5:c.269_786del,.;HGVSpClinicallyRelevant=.,NP_002114.3:p.E91Pext*12,.;ISCNCytobandNotation=del(6)p21.32;SequenceOntologyClinicallyRelevant=.,stop_lost,.;RegionClinicallyRelevant=.,exon,.;Region=6:32602269-32667519,6:32631568-32664223,6:32635668-32687441,6:32642665-32658151,6:32648003-32652753,6:32655516-32660188,6:32658868-32668015;Span2=65251,32656,51774,15487,4751,4673,9148;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap,Contains Region,Contains Region,Partial Overlap;Name=gssvL106261,gssvL106270,gssvL106263,gssvL106284,gssvL106323,gssvL106324,gssvL106294;Frequency=0.0297,0.3684,0.0171,0.0565,0.0412,0.0645,0.0368;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=6:32603525-32658123;Span3=54599;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.012685;DeletionFrequency=0.012685;DuplicationFrequency=0;END=32664908	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:27.4663:-1.5843:0.40258:0.000489083280506112:HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1::HLA-DQB1:NM_002123.5:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46611inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
6	167178374	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=3;Span=178;END=167178551	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:60.1573:-3.91479:0.252677:0.000425995638310762:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,3A0Thiscnvoverlaps0proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
7	5918824	.	N	<DEL>	.	.	Type=Loss;Targets=12;Samples2=2;Span=40272;GeneNames=CCZ1,RSPH10B;GeneIDs=51622,222967;Aliases=C7orf28A,CCZ1A,CGI-43,H_DJ1163J12.2;Genes=2;TranscriptNameClinicallyRelevant=NM_015622.6,NM_173565.5;OverlappingExonsClinicallyRelevant=11-15,7-21;HGVSg=NC_000007.14:g.5918824_5959095del;HGVScClinicallyRelevant=NM_015622.6:c.955-43_1449del,NM_173565.5:c.574-17_2613del;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(7)p22.1;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;Region2=7:5900933-5977734;Span3=76802;OverlapType2=Within Region;Type3=Deletion;Frequency2=0.00118343;DeletionFrequency=0.00118343;DuplicationFrequency=0;END=5959095	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:51.1267:-1.80322:0.563102:1.70535731165683e-08:CCZ1,RSPH10B::CCZ1:NM_015622.6:VUS:2G0TheCNVisoverlapsthehaplobenignregionISCA-46366inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
7	6780788	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=3;Span=24269;GeneNames=CCZ1B,RSPH10B2;GeneIDs=728194,221960;Genes=2;TranscriptNameClinicallyRelevant=NM_198097.5,NM_001099697.2;OverlappingExonsClinicallyRelevant=12-15,14-21;HGVSg=NC_000007.14:g.6780788_6805056dup;HGVScClinicallyRelevant=NM_198097.5:c.989-1_1449dup,NM_001099697.2:c.1530-21_2613dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(7)p22.1;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=6805056	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:72.3297:2.2051:2.87365:1.97587000594937e-09:CCZ1B,RSPH10B2::CCZ1B:NM_198097.5:VUS:2L0ThiscnvpartiallyoverlapstheCCZ1Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
8	7416738	.	N	<DUP>	.	.	Type=Gain;Targets=28;Samples2=1;Span=561221;GeneNames=DEFB4A,DEFB4B,DEFB103A,DEFB103B,DEFB104A,DEFB104B,DEFB105A,DEFB105B,DEFB106A,DEFB106B,DEFB107A,DEFB107B,FAM66E,FAM90A7,FAM90A8,FAM90A9,FAM90A10,FAM90A14,FAM90A16,FAM90A17,FAM90A18,FAM90A19,FAM90A22,FAM90A23,PRR23D1,PRR23D2,SPAG11A,SPAG11B,USP17L3,USP17L8,ZNF705B;GeneIDs=100289462,55894,10407,503618,503841,504180,503614,100131608,441317,645558,645572,645651,441326,441323,441324,728746,728753,441327,441328,100133251,245910,245908,245909,140596,653423,414325,1673,100132396,100132103,392188,645836;Aliases=DEFB4P;Genes=31;TranscriptNameClinicallyRelevant=NM_004942.4,NM_001205266.2,NM_001081551.4,NM_018661.4,NM_080389.3,NM_001040702.1,NM_152250.3,NM_001040703.3,NM_152251.4,NM_001040704.2,NM_001037668.1,NM_001040705.2,NR_027424.1,NM_001397387.1,NM_001164450.1,NM_001164448.1,NM_001164447.1,NM_001164452.1,NM_001397396.1,NM_001397391.1,NM_001164451.1,NM_001164449.1,NM_001397382.1,NM_001397380.1,NM_001282479.1,NM_001282478.1,NM_001395484.1,NM_058201.4,NM_001256871.1,NM_001256872.1,NM_001193630.1;OverlappingExonsClinicallyRelevant=All,1,All,All,All,All,All,All,All,All,All,All,1-2,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All;HGVSg=NC_000008.11:g.7416738_7977958dup;HGVScClinicallyRelevant=.,NM_001205266.2:c.1_58+32dup,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,NM_001256871.1:c.1593_1593+1ins(1566),.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,NP_001243800.1:p.532Gext*522,.,.;ISCNCytobandNotation=dup(8)p23.1;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,stop_lost,.,.;RegionClinicallyRelevant=.,exon,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,exon,.,.;Region=8:6712833-8290078,8:7067578-7617059,8:7105219-7838739,8:7296545-7617059,8:7312955-8214781,8:7409831-7598490,8:7477475-7598490,8:7667461-8036387,8:7667461-8248986,8:7706040-7952372,8:7802093-7982308;Span2=1577246,549482,733521,320515,901827,188660,121016,368927,581526,246333,180216;OverlapType=Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Within Region,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Name=gssvG36566,gssvG36571,gssvG36568,gssvG36577,gssvG36567,gssvG36583,gssvG36591,gssvG36574,gssvG36570,gssvG36582,gssvG36587;Frequency=0.0071,0.002,0.0075,0.0344,0.1192,0.0037,0.0003,0.0019,0.0009,0.0034,0.0011;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=8:7359341-7598502,8:7777183-7972317;Span3=239162,195135;OverlapType2=Partial Overlap,Contains Region;Type3=Duplication,Duplication;Frequency2=0.00152053,0.0305795;DeletionFrequency=0,0;DuplicationFrequency=0.00152053,0.0305795;END=7977958	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:125.666:1.48853:2.16099:8.36393983616214e-13:DEFB4A,DEFB4B,DEFB103A,DEFB103B,DEFB104A,DEFB104B,DEFB105A,DEFB105B,DEFB106A,DEFB106B,DEFB107A,DEFB107B,FAM66E,FAM90A7,FAM90A8,FAM90A9,FAM90A10,FAM90A14,FAM90A16,FAM90A17,FAM90A18,FAM90A19,FAM90A22,FAM90A23,PRR23D1,PRR23D2,SPAG11A,SPAG11B,USP17L3,USP17L8,ZNF705B::DEFB4B:NM_001205266.2:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-37472inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneDEFB4B.,2L0ThiscnvpartiallyoverlapstheDEFB4Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps30proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
9	64407805	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=2;Span=3481;GeneNames=ANKRD20A4-ANKRD20A20P;GeneIDs=110006327;Genes=1;TranscriptNameClinicallyRelevant=NR_146419.1;OverlappingExonsClinicallyRelevant=13-15;HGVSg=NC_000009.12:g.64407805_64411285del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(9)q13;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=64411285	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:37.7047:-2.23205:0.411232:5.78524398257225e-05:ANKRD20A4-ANKRD20A20P::ANKRD20A4-ANKRD20A20P:NR_146419.1:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-46421inClinGenDosageSensitivity.,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
10	47502112	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=2138;GeneNames=AGAP9,BMS1P2-AGAP9;GeneIDs=113939912,642517;Genes=2;TranscriptNameClinicallyRelevant=NM_001190810.1,NR_160415.1;OverlappingExonsClinicallyRelevant=7-8,15-16;HGVSg=NC_000010.11:g.47502112_47504249del;HGVScClinicallyRelevant=NM_001190810.1:c.534-9_1977del,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(10)q11.22;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;END=47504249	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:57.5688:-2.30577:0.351095:0.000327194242651128:AGAP9,BMS1P2-AGAP9::AGAP9:NM_001190810.1:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-46442inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
11	4946129	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=1000;GeneNames=MMP26,OR51A4;GeneIDs=56547,401666;Genes=2;TranscriptNameClinicallyRelevant=NM_021801.5,NM_001005329.2;OverlappingExonsClinicallyRelevant=.,2;HGVSg=NC_000011.10:g.4946129_4947128dup;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(11)p15.4;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;END=4947128	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:321.083:3.95937:1.86183:0.000354337018176597:MMP26,OR51A4::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
11	61207497	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=41047;GeneNames=PGA3,PGA4,PGA5;GeneIDs=643834,643847,5222;Genes=3;TranscriptNameClinicallyRelevant=NM_001079807.4,NM_001079808.6,NM_014224.5;OverlappingExonsClinicallyRelevant=4-9,All,1-6;HGVSg=NC_000011.10:g.61207497_61248543dup;HGVScClinicallyRelevant=NM_001079807.4:c.338_1167dup,.,NM_014224.5:c.1_773+8dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(11)q12.2;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,.,transcript_ablation;RegionClinicallyRelevant=UTR3,.,exon;Region=11:61194479-61257898;Span2=63420;OverlapType=Within Region;Name=gssvG6800;Frequency=0.2426;Type2=Gain;Region2=11:61198363-61217590;Span3=19228;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=61248543	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:127.239:3.34773:1.80418:1.50613682340495e-07:PGA3,PGA4,PGA5::PGA3:NM_001079807.4:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46660inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggenePGA3.,2L0ThiscnvpartiallyoverlapsthePGA3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
11	89968482	.	N	<DUP>	.	.	Type=Gain;Targets=12;Samples2=5;Span=118678;GeneNames=TRIM49C,TRIM51EP,TRIM53AP,TRIM64,UBTFL1;GeneIDs=120146,399940,642569,642612,642623;Aliases=C11orf28,TRIM64A;Genes=5;TranscriptNameClinicallyRelevant=NM_001195234.1,NR_146921.1,NR_028346.1,NM_001136486.2,NM_001143975.1;OverlappingExonsClinicallyRelevant=All,All,All,2-7,All;HGVSg=NC_000011.10:g.89968482_90087159dup;HGVScClinicallyRelevant=.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(11)q14.3;SequenceOntologyClinicallyRelevant=.,.,.,.,.;RegionClinicallyRelevant=.,.,.,.,.;END=90087159	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:72.693:1.56505:2.16202:8.86750210749338e-07:TRIM49C,TRIM51EP,TRIM53AP,TRIM64,UBTFL1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps3proteincodinggenes:3
12	7921507	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=1;Span=14581;GeneNames=SLC2A3;GeneIDs=6515;Aliases=GLUT3;Genes=1;TranscriptNameClinicallyRelevant=NM_006931.3;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000012.12:g.7921507_7936087dup;HGVScClinicallyRelevant=NM_006931.3:c.1_1397dup;HGVSpClinicallyRelevant=NP_008862.1:p.G467Wfs*10;ISCNCytobandNotation=dup(12)p13.31;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region2=12:7899939-7930577;Span3=30639;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00473373;DeletionFrequency=0;DuplicationFrequency=0.00473373;END=7936087	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:182.589:2.35891:1.30213:1.30418656955192e-11:SLC2A3::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
14	73543041	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=30559;GeneNames=ACOT1,ACOT2,HEATR4;GeneIDs=399671,641371,10965;Genes=3;TranscriptNameClinicallyRelevant=NM_001037161.2,NM_006821.6,NM_001220484.1;OverlappingExonsClinicallyRelevant=3,1-2,1;HGVSg=NC_000014.9:g.73543041_73573599dup;HGVScClinicallyRelevant=NM_001037161.2:c.661-9_1266dup,NM_006821.6:c.1_846+9dup,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(14)q24.3;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.;RegionClinicallyRelevant=exon,exon,.;Region=14:73522514-73587026,14:73526068-73564788,14:73529057-73554275,14:73543186-73559754,14:73549142-73584725,14:73560291-73574863,14:73564692-73583598;Span2=64513,38721,25219,16569,35584,14573,18907;OverlapType=Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap,Partial Overlap;Name=gssvG11563,gssvG11570,gssvG11571,gssvG11575,gssvG11569,gssvG11576,gssvG11572;Frequency=0.0057,0.0371,0.006,0.037,0.1045,0.0302,0.0137;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=14:73527685-73585263,14:73528139-73585536,14:73543917-73556479,14:73552833-73574824,14:73553840-73564094;Span3=57579,57398,12563,21992,10255;OverlapType2=Within Region,Within Region,Contains Region,Partial Overlap,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.644444,0.875,0.0153846,0.025,0.016568;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.644444,0.875,0.0153846,0.025,0.016568;END=73573599	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:200.141:3.12503:1.40702:9.5551770044876e-07:ACOT1,ACOT2,HEATR4::ACOT1:NM_001037161.2:Benign:2L0ThiscnvpartiallyoverlapstheACOT1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
14	105597685	.	N	<DEL>	.	.	Type=Loss;Targets=9;Samples2=3;Span=106909;GeneNames=ELK2AP,MIR8071-1,MIR8071-2;GeneIDs=102465871,102466889,2003;Aliases=hsa-mir-8071-1;Genes=3;TranscriptNameClinicallyRelevant=NR_046211.1,NR_107038.1,NR_107059.1;OverlappingExonsClinicallyRelevant=All,All,All;HGVSg=NC_000014.9:g.105597685_105704593del;HGVScClinicallyRelevant=.,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=del(14)q32.33;SequenceOntologyClinicallyRelevant=.,.,.;RegionClinicallyRelevant=.,.,.;Region=14:105474495-105757250,14:105563300-105707264,14:105588517-105776221,14:105589882-105862880,14:105600482-105633783,14:105601281-105666727,14:105612353-105702719,14:105614329-105642193,14:105646503-105756479,14:105651835-105679415;Span2=282756,143965,187705,272999,33302,65447,90367,27865,109977,27581;OverlapType=Within Region,Within Region,Within Region,Within Region,Contains Region,Contains Region,Contains Region,Contains Region,Partial Overlap,Contains Region;Name=gssvL37133,gssvL37151,gssvL37139,gssvL37127,gssvL37230,gssvL37186,gssvL37162,gssvL37252,gssvL37157,gssvL37229;Frequency=0.0016,0.0215,0.0079,0.0046,0.0094,0.0231,0.0031,0.6476,0.0338,0.023;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=14:105520766-105769838;Span3=249073;OverlapType2=Within Region;Type3=Deletion;Frequency2=0.0133333;DeletionFrequency=0.0133333;DuplicationFrequency=0;END=105704593	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:57.3605:-2.25687:0.468832:9.46915142606469e-10:ELK2AP,MIR8071-1,MIR8071-2::ELK2AP:NR_046211.1:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37477inClinGenDosageSensitivity.,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
14	105904479	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=2;Span=9932;Region2=14:105897171-105918491;Span3=21321;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=105914410	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:187.387:1.43236:1.39537:0.000249197840658764:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2D-1ThecnvissmallerthanthetriplobenignregionISCA-37477inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps0proteincodinggenes:3
15	82431829	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=3;Span=4577;GeneNames=GOLGA6L9;GeneIDs=440295;Aliases=GOLGA6L20;Genes=1;TranscriptNameClinicallyRelevant=NM_198181.4;OverlappingExonsClinicallyRelevant=2-9;HGVSg=NC_000015.10:g.82431829_82436405dup;HGVScClinicallyRelevant=NM_198181.4:c.85-1_1293dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(15)q25.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=82436405	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:74.5104:1.9966:1.67078:0.000310061097173096:GOLGA6L9::GOLGA6L9:NM_198181.4:Benign:2L0ThiscnvpartiallyoverlapstheGOLGA6L9genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	32066194	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=224;END=32066417	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:69.8527:-4.51349:0.475828:4.69409951074132e-05:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,3A0Thiscnvoverlaps0proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
16	32253335	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=2;Span=756344;GeneNames=LOC390705,SLC6A10P,TP53TG3,TP53TG3D;GeneIDs=729264,390705,24150,386757;Genes=4;TranscriptNameClinicallyRelevant=NR_033866.1,NR_003083.3,NM_016212.5,NM_001243722.3;OverlappingExonsClinicallyRelevant=All,All,All,All;HGVSg=NC_000016.10:g.32253335_33009678dup;HGVScClinicallyRelevant=.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(16)p11.2;SequenceOntologyClinicallyRelevant=.,.,.,.;RegionClinicallyRelevant=.,.,.,.;Region=16:31738132-32732148,16:31943783-34000847,16:31960187-33293308,16:32016645-32473866,16:32069540-32703085,16:32169453-33002529,16:32286410-32775600,16:32436683-32650712,16:32447067-33967525,16:32471086-33043325,16:32471693-32804488,16:32612925-33521177,16:32731968-33045427,16:32846168-33028850;Span2=994017,2057065,1333122,457222,633546,833077,489191,214030,1520459,572240,332796,908253,313460,182683;OverlapType=Partial Overlap,Within Region,Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Contains Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap,Partial Overlap;Name=gssvG14621,gssvG14616,gssvG14619,gssvG14632,gssvG14627,gssvG14624,gssvG14635,gssvG14651,gssvG14618,gssvG14630,gssvG14638,gssvG14622,gssvG14644,gssvG14652;Frequency=0.0062,0.0467,0.0046,0.0004,0.0075,0.0036,0.0041,0.0048,0.0048,0.002,0.0005,0.0002,0.0003,0.194;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=16:32313386-32762318,16:32445626-32650712,16:32847803-33026824;Span3=448933,205087,179022;OverlapType2=Contains Region,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.525,0.766667,0.275;DeletionFrequency=0,0,0;DuplicationFrequency=0.525,0.766667,0.275;END=33009678	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:156.879:3.06931:1.57341:9.19339013995533e-12:LOC390705,SLC6A10P,TP53TG3,TP53TG3D::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	33802698	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=7;Span=42590;Region=16:33673963-33865333,16:33754554-33825160,16:33754554-33865333,16:33786065-33829199,16:33792173-33861400,16:33813701-33829199;Span2=191371,70607,110780,43135,69228,15499;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap,Within Region,Contains Region;Name=gssvL43712,gssvL43734,gssvL43730,gssvL43756,gssvL43732,gssvL43789;Frequency=0.0067,0.0007,0.0009,0.0055,0.0026,0.0052;Type2=Loss,Loss,Loss,Loss,Loss,Loss;END=33845287	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:48.8036:-3.86082:0.414738:2.81743271987155e-12:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,3A0Thiscnvoverlaps0proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
16	70120454	.	N	<DUP>	.	.	Type=Gain;Targets=18;Samples2=2;Span=54599;GeneNames=CLEC18C,LOC400541,PDPR;GeneIDs=55066,400541,283971;Aliases=PDP3;Genes=3;TranscriptNameClinicallyRelevant=NM_173619.4,NR_126007.1,NM_017990.5;OverlappingExonsClinicallyRelevant=1-3,All,3-19;HGVSg=NC_000016.10:g.70120454_70175052dup;HGVScClinicallyRelevant=NM_173619.4:c.1_216+14dup,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(16)q22.1;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.;RegionClinicallyRelevant=exon,.,.;Region=16:70090445-70251178,16:70111451-70179141,16:70141045-70164354,16:70142379-70179141;Span2=160734,67691,23310,36763;OverlapType=Within Region,Within Region,Contains Region,Partial Overlap;Name=gssvG15176,gssvG15182,gssvG15193,gssvG15186;Frequency=0.0038,0.0647,0.4569,0.002;Type2=Gain,Gain,Gain,Gain;Region2=16:70106838-70177676,16:70111452-70162599,16:70117625-70247875,16:70130436-70143532,16:70145441-70179141;Span3=70839,51148,130251,13097,33701;OverlapType2=Within Region,Partial Overlap,Within Region,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.00523737,0.755556,0.00101369,0.00118343,0.00067579;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.00523737,0.755556,0.00101369,0.00118343,0.00067579;END=70175052	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:206.705:3.49143:1.8107:3.17935886766823e-41:CLEC18C,LOC400541,PDPR::CLEC18C:NM_173619.4:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46493inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneCLEC18C.,2L0ThiscnvpartiallyoverlapstheCLEC18Cgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	74385337	.	N	<DUP>	.	.	Type=Gain;Targets=20;Samples2=6;Span=35931;GeneNames=CLEC18B,LOC105376772,NPIPB15;GeneIDs=440348,105376772,497190;Aliases=A-761H5.4,NPIPL2;Genes=3;TranscriptNameClinicallyRelevant=NM_001385193.1,NR_135170.1,NM_001306094.2;OverlappingExonsClinicallyRelevant=All,All,4-8;HGVSg=NC_000016.10:g.74385337_74421267dup;HGVScClinicallyRelevant=NM_001385193.1:c.4_1341dup,.,NM_001306094.2:c.250-5_1332dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(16)q23.1;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,.,transcript_ablation;RegionClinicallyRelevant=UTR3,.,exon;Region=16:74303138-74473158,16:74337368-74432521,16:74359803-74400402,16:74393258-74431487;Span2=170021,95154,40600,38230;OverlapType=Within Region,Within Region,Partial Overlap,Partial Overlap;Name=gssvG15269,gssvG15270,gssvG15273,gssvG15274;Frequency=0.0044,0.0697,0.7163,1;Type2=Gain,Gain,Gain,Gain;Region2=16:74305874-74429541,16:74363161-74469071,16:74374985-74396665;Span3=123668,105911,21681;OverlapType2=Within Region,Within Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.1,0.000168947,0.025;DeletionFrequency=0,0,0;DuplicationFrequency=0.1,0.000168947,0.025;END=74421267	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:280.159:2.4441:1.63958:3.2251141043819e-23:CLEC18B,LOC105376772,NPIPB15::NPIPB15:NM_001306094.2:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46693inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneNPIPB15.,2L0ThiscnvpartiallyoverlapstheNPIPB15genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	46094551	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=12;Span=203200;GeneNames=ARL17B,KANSL1,KANSL1-AS1,LRRC37A;GeneIDs=284058,644246,100506084,9884;Aliases=CENP-36,KDVS,KIAA1267,MSL1v1,hMSL1v1;Genes=4;TranscriptNameClinicallyRelevant=NM_001103154.2,NM_001193466.2,NR_034172.1,NM_014834.4;OverlappingExonsClinicallyRelevant=5,1-3,All,1;HGVSg=NC_000017.11:g.46094551_46297750del;HGVScClinicallyRelevant=.,NM_001193466.2:c.1_1431+9del,.,NM_014834.4:c.1_2609+8del;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=del(17)q21.31;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.,transcript_ablation;RegionClinicallyRelevant=.,exon,.,exon;Region=17:46088437-46276519,17:46088904-46234597,17:46092761-47091135,17:46099606-46380808,17:46114400-46177128,17:46114400-46214953,17:46146542-46717206,17:46151528-46215377,17:46169584-46291969,17:46176257-46218456,17:46228609-46289299;Span2=188083,145694,998375,281203,62729,100554,570665,63850,122386,42200,60691;OverlapType=Partial Overlap,Partial Overlap,Within Region,Partial Overlap,Contains Region,Contains Region,Partial Overlap,Contains Region,Contains Region,Contains Region,Contains Region;Name=gssvL49597,gssvL49601,gssvL49591,gssvL49596,gssvL49609,gssvL49606,gssvL49593,gssvL49607,gssvL49603,gssvL49617,gssvL49608;Frequency=0.0039,0.0151,0.0221,0.0153,0.0013,0.0038,0.1703,0.0004,0.0043,0.0004,0.001;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;END=46297750	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:60.7276:-1.62331:0.582707:0.000351511983538468:ARL17B,KANSL1,KANSL1-AS1,LRRC37A:KANSL1:KANSL1:NM_001193466.2:VUS:2C-10.9Thecnvoverlapsthe5'endoftheKANSL1geneandthecodingsequenceisinvolved,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
19	7040063	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=4;Span=16850;GeneNames=MBD3L2,MBD3L3,MBD3L4;GeneIDs=653656,125997,653657;Genes=3;TranscriptNameClinicallyRelevant=NM_144614.4,NM_001164425.4,NM_001164419.3;OverlappingExonsClinicallyRelevant=All,2,1;HGVSg=NC_000019.10:g.7040063_7056912dup;HGVScClinicallyRelevant=.,NM_001164425.4:c.46-9_627dup,NM_001164419.3:c.1_45+37dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(19)p13.2;SequenceOntologyClinicallyRelevant=.,transcript_ablation,transcript_ablation;RegionClinicallyRelevant=.,exon,exon;Region=19:7014426-7063202;Span2=48777;OverlapType=Within Region;Name=gssvG18373;Frequency=0.0168;Type2=Gain;END=7056912	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:225.988:3.41493:2.04048:8.42563579296078e-08:MBD3L2,MBD3L3,MBD3L4::MBD3L3:NM_001164425.4:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46505inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneMBD3L3.,2L0ThiscnvpartiallyoverlapstheMBD3L3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	41121449	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=178;GeneNames=CYP2F1;GeneIDs=1572;Aliases=C2F1,CYP2F,CYPIIF1;Genes=1;TranscriptNameClinicallyRelevant=NM_000774.5;OverlappingExonsClinicallyRelevant=5;HGVSg=NC_000019.10:g.41121449_41121626del;HGVScClinicallyRelevant=NM_000774.5:c.485-9_645+8del;HGVSpClinicallyRelevant=NP_000765.2:p.G162Vfs*79;ISCNCytobandNotation=del(19)q13.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region2=19:41121414-41121602;Span3=189;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.0035503;DeletionFrequency=0.0035503;DuplicationFrequency=0;END=41121626	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-5.3999:0:1.06940751501832e-06:CYP2F1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:0
19	43196763	.	N	<DEL>	.	.	Type=Loss;Targets=10;Samples2=10;Span=62381;GeneNames=LOC284344,PSG4,PSG9;GeneIDs=5672,284344,5678;Aliases=PSBG-4,PSBG-9;Genes=3;TranscriptNameClinicallyRelevant=NR_033888.1,NM_002780.5,NM_002784.5;OverlappingExonsClinicallyRelevant=All,1-3,4-6;HGVSg=NC_000019.10:g.43196763_43259143del;HGVScClinicallyRelevant=.,NM_002780.5:c.1_709+1234del,NM_002784.5:c.710-8_1281del;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=del(19)q13.31;SequenceOntologyClinicallyRelevant=.,transcript_ablation,transcript_ablation;RegionClinicallyRelevant=.,exon,exon;Region=19:43004776-43252073,19:43064239-43372382,19:43103971-43264030,19:43177612-43271565,19:43181987-43236801,19:43208086-43254431,19:43209447-43372249,19:43219399-43287524;Span2=247298,308144,160060,93954,54815,46346,162803,68126;OverlapType=Partial Overlap,Within Region,Within Region,Within Region,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap;Name=gssvL58689,gssvL58688,gssvL58695,gssvL58701,gssvL58709,gssvL58713,gssvL58694,gssvL58705;Frequency=0.0008,0.0087,0.0205,0.1325,0.0018,0.0007,0.0005,0.031;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=19:43013179-43282228,19:43043383-43340945,19:43044863-43252085,19:43162745-43340945,19:43196785-43260652,19:43209060-43236813;Span3=269050,297563,207223,178201,63868,27754;OverlapType2=Within Region,Within Region,Partial Overlap,Within Region,Partial Overlap,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.0306554,0.0035503,0.00067579,0.00118343,0.22093,0.000337895;DeletionFrequency=0.0306554,0.0035503,0.00067579,0.00118343,0.22093,0.000337895;DuplicationFrequency=0,0,0,0,0,0;END=43259143	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:8.5389:-3.49614:0.0687625:1.37210009911371e-23:LOC284344,PSG4,PSG9::LOC284344:NR_033888.1:Benign:2F-1ThecnvdoesnotincludeanyproteincodinggenesoutsideoftheknownhaplobenignregionISCA-46507inClinGenDosageSensitivity.,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
19	54724454	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=7;Span=5333;GeneNames=KIR3DL3;GeneIDs=115653;Aliases=CD158Z,KIR3DL7,KIR44,KIRC1;Genes=1;TranscriptNameClinicallyRelevant=NM_153443.5;OverlappingExonsClinicallyRelevant=1-5;HGVSg=NC_000019.10:g.54724454_54729786dup;HGVScClinicallyRelevant=NM_153443.5:c.1_949dup;HGVSpClinicallyRelevant=NP_703144.3:p.G317Dfs*41;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=54729786	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:149.07:1.95039:1.55866:8.01824812158479e-05:KIR3DL3::KIR3DL3:NM_153443.5:Benign:2L0ThiscnvpartiallyoverlapstheKIR3DL3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	55762528	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=5;Span=10721;GeneNames=RFPL4A,RFPL4AL1;GeneIDs=342931,729974;Aliases=RFPL4,RNF210;Genes=2;TranscriptNameClinicallyRelevant=NM_001145014.2,NM_001277397.2;OverlappingExonsClinicallyRelevant=3,All;HGVSg=NC_000019.10:g.55762528_55773248dup;HGVScClinicallyRelevant=NM_001145014.2:c.287-70_864dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=19:55751548-55797784,19:55754759-55781580,19:55756662-55766687,19:55766502-55778198;Span2=46237,26822,10026,11697;OverlapType=Within Region,Within Region,Partial Overlap,Partial Overlap;Name=gssvG19472,gssvG19478,gssvG19480,gssvG19479;Frequency=0.0002,0.0052,0.2338,0.1058;Type2=Gain,Gain,Gain,Gain;END=55773248	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:269.191:2.3912:1.60801:0.000183000517995815:RFPL4A,RFPL4AL1::RFPL4A:NM_001145014.2:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46717inClinGenDosageSensitivitybutincludesadditionalmaterial.,2L0ThiscnvpartiallyoverlapstheRFPL4Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	58436224	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=1;Span=3626;GeneNames=ZNF132;GeneIDs=7691;Aliases=pHZ-12;Genes=1;TranscriptNameClinicallyRelevant=NM_003433.4;OverlappingExonsClinicallyRelevant=1-2;HGVSg=NC_000019.10:g.58436224_58439849del;HGVScClinicallyRelevant=NM_003433.4:c.1_232+823del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(19)q13.43;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=58439849	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:69.2542:-3.57126:0.601145:1.04615277948676e-10:ZNF132::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
22	23957713	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=2;Span=13935;GeneNames=DDT,DDTL,GSTT2B;GeneIDs=653689,100037417,1652;Aliases=GSTT2P;Genes=3;TranscriptNameClinicallyRelevant=NM_001084392.3,NM_001084393.2,NM_001080843.4;OverlappingExonsClinicallyRelevant=3,All,All;HGVSg=NC_000022.11:g.23957713_23971647dup;HGVScClinicallyRelevant=NM_001084392.3:c.285-24_357dup,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(22)q11.23;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.;RegionClinicallyRelevant=exon,.,.;Region=22:23927243-23971405;Span2=44163;OverlapType=Partial Overlap;Name=gssvG24274;Frequency=0.001;Type2=Gain;END=23971647	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:183.754:2.25751:1.48538:5.45044048040058e-07:DDT,DDTL,GSTT2B::DDT:NM_001084392.3:Benign:2L0ThiscnvpartiallyoverlapstheDDTgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
22	23998523	.	N	<DEL>	.	.	Type=Loss;Targets=5;Samples2=2;Span=6837;GeneNames=GSTT4;GeneIDs=25774;Aliases=GSTTP1,HS322B1A;Genes=1;TranscriptNameClinicallyRelevant=NM_001358664.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000022.11:g.23998523_24005359del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(22)q11.23;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=22:23986152-24008337;Span2=22186;OverlapType=Within Region;Name=gssvL77249;Frequency=0.0313;Type2=Loss;END=24005359	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:52.1629:-2.59616:0.516788:1.58277051295067e-07:GSTT4::GSTT4:NM_001358664.2:Benign:2B0WhiletheCNVoverlapstheGSTT4geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-46292inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
X	55077401	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=PAGE2B;GeneIDs=389860;Aliases=CT16.5,GAGEE3,PAGE-2B;Genes=1;TranscriptNameClinicallyRelevant=NM_001015038.3;OverlappingExonsClinicallyRelevant=4;HGVSg=NC_000023.11:g.55077401_55077520dup;HGVScClinicallyRelevant=NM_001015038.3:c.195_196ins(120);HGVSpClinicallyRelevant=NP_001015038.1:p.P66_E105dup;ISCNCytobandNotation=dup(X)p11.21;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=55077520	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:158.875:4.6681:1.64885:2.45229312245301e-05:PAGE2B::PAGE2B:NM_001015038.3:VUS:2L0ThiscnvpartiallyoverlapsthePAGE2Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
